Skip to content

Enum: ClinicalTrialPhaseEnum

Clinical trial phase categories per FDA/NIH standards

URI: dismech:ClinicalTrialPhaseEnum

Permissible Values

Value Meaning Description
PHASE_I None Phase I - Initial safety and dosage assessment in small group (20-100 partici...
PHASE_II None Phase II - Efficacy and side effects assessment in larger group (100-500 part...
PHASE_III None Phase III - Efficacy confirmation and monitoring in large population (1000-50...
PHASE_IV None Phase IV - Post-market surveillance and additional benefits/risks studies
NOT_APPLICABLE None Trial does not follow standard FDA phase classification (e

Slots

Name Description
phase Trial phase (Phase I, Phase II, Phase III, Phase IV, or Not Applicable)

Identifier and Mapping Information

Schema Source

  • from schema: https://w3id.org/monarch-initiative/dismech

LinkML Source

name: ClinicalTrialPhaseEnum
description: Clinical trial phase categories per FDA/NIH standards
from_schema: https://w3id.org/monarch-initiative/dismech
rank: 1000
permissible_values:
  PHASE_I:
    text: PHASE_I
    description: Phase I - Initial safety and dosage assessment in small group (20-100
      participants)
  PHASE_II:
    text: PHASE_II
    description: Phase II - Efficacy and side effects assessment in larger group (100-500
      participants)
  PHASE_III:
    text: PHASE_III
    description: Phase III - Efficacy confirmation and monitoring in large population
      (1000-5000 participants)
  PHASE_IV:
    text: PHASE_IV
    description: Phase IV - Post-market surveillance and additional benefits/risks
      studies
  NOT_APPLICABLE:
    text: NOT_APPLICABLE
    description: Trial does not follow standard FDA phase classification (e.g., observational,
      device studies)